AbbVie Announces International Skyrizi Approval

19/04/2019 iData Research

Register to receive a free Global Immunology Drugs Market Report Suite report synopsis and brochure The Japan Ministry of Health, Labour and Welfare has recently approved AbbVie’s Skyrizi for trea... Read More

Psoriasis Treatments to Become Cheaper as Biosimilars Compete in $5 Billion U.S. Psoriasis Drugs Market – New Study by iData Research

20/06/2018 iData Research

Register to receive a free Global Immunology Drugs Market Report Suite 2018-2024 report synopsis and brochure A new study by iData Research estimates that there are nearly 150,000 new cases of pso... Read More

Biosimilars – A Game Changer in the Immunology Rheumatoid Arthritis Market

17/10/2017 iData Research

Biosimilars are, as the name would suggest, highly similar and are a more affordable alternative to biologics that is poised to influence the current dynamics of the immunology market. ... Read More